Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection

Diabetes, Obesity and Metabolism

Volumn 3, Issue 5, 2001, Pages 332-337

  Yonem A ^a   Cakir B ^b   Guler S ^b,c   Azal, O ^a   Corakci A ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Diabetes mellitus; Diabetic foot infection; Granulocyte colony stimulating factor; Phagocytosis; Polymorphonuclear leucocytes; Respiratory burst

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; METRONIDAZOLE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DRUG EFFECT; DRUG MECHANISM; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INFECTION SENSITIVITY; LEG AMPUTATION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PHAGOCYTOSIS; RESPIRATORY BURST; WOUND CARE;

EID: 0035161166     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2001.00142.x     Document Type: Article

References (24)

1. The size of the problem: Epidemiological and economical aspects of foot problems in diabetes
2. Diabetic foot infections: Pathophysiology and treatment
3. Diabetic foot infections
4. Chemotaxis of polymorphonuclear leucocytes from patients with diabetes mellitus
5. Defective phagocytosis in insulin controlled diabetes: Evidence for a reaction between glucose and opsonising proteins
6. Infection, immunity and diabetes
7. Oxygen metabolism and the toxic properties of phagocytes
8. Defective phagocytosis in insulin controlled diabetics: Evidence for a reaction between glucose and opsonising proteins
9. Activation of the respiratory burst enzyme in human polymorphonuclear leucocytes by chemoattractants and other soluble stimuli: Evidence that the same oxidase is activated by different transductional mechanisms
10. Recombinant granulocyte colony-stimulating factor: A review of its pharmacological properties and prospective role in neutropenic conditions
11. Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections
12. Endogenous haemopoietic growth factors in neutropenia and infection
13. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective neutrophils
14. Probing to bone in infected pedal ulcers: A clinical sign of underlying osteomyelitis in diabetic patients
15. Systemic antimicrobial treatment of foot infections in diabetic patients
16. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus
17. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro
18. Role of granulocyte colony-stimulating factor in the immune response to acute bacterial infection in the non-neutropenic host: An overview
19. Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers
20. Improvement of an impaired chemiluminescence response to formyl-methionyl-leucyl-phenylalanine in neutrophils from patients with non insulin dependent diabetes mellitus by recombinant human granulocyte-colony stimulating factor
21. Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients
22. Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats
23. Leucocytes and the risk of ischemic disease
24. Randomized placebo controlled trial of granulocyte-colony stimulating factor in diabetic foot infection